BRITTAIN, JASON, EDWARD,SEIDERS, THOMAS, JON,KING, CHRISTOPHER, DAVID,ROSSO, VICTOR, W.
申请号：
SG2013043740
公开号：
SG191041A1
申请日:
2011.12.07
申请国别(地区):
SG
年份:
2013
代理人:
摘要：
Described herein is the LPA1 antagonist 1- {4-[3-methyl-4-((R)- l-phenyl-ethoxycarbonylamino)- isoxazol-5-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid (Compound 1), or pharmaceutically acceptable salts thereof. Also described are methods of preparing the LPA1 antagonist, or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions suitable for administration to a mammal that include the LPA1 antagonist, or pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating LPA-dependent or LPA- mediated diseases or conditions.
